Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-15-008059)

Filing Details

Accession Number:: 0001181431-15-008059
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-06-09 17:04:04
Reporting Period:: 2015-06-08

Filing Date:: 2015-06-09
Accepted Time:: 2015-06-09 17:04:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1567514	Intra-Cellular Therapies Inc.	ITCI	Pharmaceutical Preparations (2834)	364742850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1585663	P. Lawrence Wennogle	C/O Intra-Cellular Therapies, Inc. 430 East 29Th Street New York NY 10016	Vice President, Drug Discovery	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-06-08	25,000	$26.84	126,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2015.